The number is down from 62 hospitals last year and 66 the before, but will still cost many hospitals money while they are still dealing with the strain of the pandemic that has overwhelmed resources and reduced their revenue and profits.
Tensions boil between ER docs, insurers as no-surprises law rolls out
The federal No Surprises Act—which took effect Jan. 1 and protects patients from receiving surprise medical bills resulting from unexpected, out-of-network coverage—is already creating huge waves.Read More
Battle over where to purchase specialty drugs hits Indiana
Health care practitioners and insurers are fighting over the hefty prices hospitals charge for specialty drugs to treat patients with cancer, vision loss, low white-blood-cell count and other serious diseases.Read More
Net patient revenue for the first nine months of the year increased an undisclosed amount, driven by an increase in volumes in many areas. Patient days climbed 5% and admissions rose 5.7% during the period.
A high concentration of hospital, physician and insurance markets in Indiana have likely contributed to health care costs soaring 48% in a recent nine-year period, according to a new study commissioned by state lawmakers.
A new study released Thursday by the Rand Corp. showed that Hoosiers covered by employer health plans paid Indiana hospitals nearly three times—or 292%—of what Medicare would have paid for the same procedures.
When it comes to who is responsible for the high cost of health care, many of the organizations pointed fingers to different players in the wide-ranging industry.
House Speaker Todd Huston and Senate President Rodric Bray sent a joint letter Tuesday to 20 hospital and insurance executives, telling them to submit a plan by April 1 that would lower Indiana’s hospital prices to the national average or lower by 2025.
Indiana University Health, which charges the highest hospital fees in the Indianapolis area and is sitting on nearly $9 billion in cash and investments, said it is freezing prices through 2025 to help get in line with national average prices.
Separately, Dr. Aaron Kesselheim of Harvard University became the third member of an FDA advisory panel that opposed the drug to step down over the decision to approve it.
Haven, which was formed in 2018 by Amazon, Berkshire Hathaway and JPMorgan to attack soaring costs, will cease operations by the end of February.
A new study released Friday by the Rand Corp. found that Hoosiers covered by employer health plans paid Indiana hospitals three times what Medicare would have paid for the same procedures, exceeding the national rate of disparity.
Three years after Indiana passed a law allowing doctors to prescribe drugs for patients without an in-person visit—using a computer, smartphone, video camera and similar technology—some health systems around the state are reporting higher use of virtual visits. St. Vincent, for example, sees hundreds of patients a month remotely for ailments ranging from minor rashes and sprains to follow-up visits for strokes.
The Trump administration has finalized regulations that will require drug companies to disclose list prices of medications costing more than $35 for a month’s supply.
Local tech firm, Springbuk, has grown from 16 to 102 employees in a little more than two years. A recently released product upgrade the company is calling “a game changer” is spurring another round of serious growth.
The suit accuses the companies of raising insulin sticker prices by more than 150 percent over five years, forcing diabetics to forgo the drug, take less insulin than needed or use expired versions
Eli Lilly and Co. won’t put the price of its prescription drugs in television ads, as the Trump administration has called for pharmaceutical companies to do, but will begin promoting a website where prices are available.
Starting Jan. 1, every U.S. hospital will be required to post standard charges online for every item and service they provide, from bandages and drugs to operating rooms and organ transplants.
Two reports, sponsored by the Richard M. Fairbanks Foundation, say the state should not let up in fighting twin scourges that claim thousands of lives and cost billions of dollars in health care costs and lost productivity.
President Donald Trump is linking the drug prices Americans complain about to one of his longstanding grievances: foreign countries the president says are taking advantage of U.S. research breakthroughs.
Indiana hospitals are racking up millions of dollars in penalties for having too many patients return for care within a month of discharge.